Thermo Fisher Scientific and Glatt to Jointly Deliver Continuous Twin-screw Granulation and Drying Solutions

Thermo Fisher Scientific Inc., has announced a collaboration with integrated process technology provider Glatt GmbH to deliver continuous twin-screw granulation and drying solutions for the pharmaceutical industry.

Together, the two companies provide a one-stop solution for satisfying customer demands from powder handling to tablet production.

“To improve performance and yield in production processes, pharmaceutical companies are increasingly adopting continuous processing, especially for granulation,”, said Markus Schreyer, vice president and general manager of the Thermo Fisher Scientific’s material characterization business.

Schreyer continued, “Our customers have confirmed that twin-screw granulation is the next step in continuous processing because it simplifies scale-up, and we’re able to offer a comprehensive twin-screw granulation portfolio to meet their specific needs, from research and development to production.”

While many pharmaceutical companies still use batch process technologies, interest in continuous processing has increased because companies want to further reduce manufacturing costs and improve performance.

“Glatt already serves customers using continuous process technologies in the food, feed and fine chemical sectors, and the pharmaceutical industry is next for this innovation,” said Thomas Hofmaier, head of Glatt’s pharma process technologies business unit.

Hofmaier continued, “Combining Thermo Scientific twin-screw granulation technology with Glatt’s continuous drying technologies, as well as our complementary expertise in system integration and applications, offers a unique and beneficial solution to our customers.”